A Study of Chios Mastic Water in Irritable Bowel Syndrome
NCT04893499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2022-09-29
Summary
Chios mastic is a natural product with strong antimicrobial, anti-inflammatory and antioxidant properties, and well-established benefits for dyspeptic disorders. The aim of the present study is to investigate the effectiveness of a natural aqueous extract of Chios mastic (mastic water), a by-product of Chios mastic processing, in the management of irritable bowel syndrome. This will be a 3-month randomized double-blind controlled clinical trial in adult patients with irritable bowel syndrome under standard medication. Participants will be blindly randomized to a low-dose mastic group, which will receive a carbonated water enriched with Chios mastic water (0.06%), a high-dose mastic group, which will receive a carbonated fruit juice enriched with Chios mastic water (0.55%), or one of the two control groups, which will receive an identical placebo water/fruit juice with no active ingredients. Participants will be evaluated in terms of anthropometric indices, lifestyle habits, severity of IBS-related gastrointestinal symptoms, quality of life, as well as biochemical, inflammatory and oxidative stress markers, both pre- and post-intervention.
Conditions
- Irritable Bowel Syndrome
Interventions
- BEHAVIORAL
-
Chios mastic water
Participants randomized to this intervention arm will be provided with a sparkling water enriched with the natural mastic aqueous extract (0.06%), a by-product of Chios mastic processing, and will be asked to consume it daily (3 bottles of 200 mL each) for 3 months. Participants will also be instructed to keep the use of medication and dietary supplements stable and preserve their typical lifestyle habits throughout the study.
- BEHAVIORAL
-
Placebo water
Participants randomized to this intervention arm will be provided with a standard sparkling water and will be asked to consume it daily (3 bottles of 200 mL each) for 3 months. Participants will also be instructed to keep the use of medication and dietary supplements stable and preserve their typical lifestyle habits throughout the study.
- BEHAVIORAL
-
Chios mastic fruit juice
Participants randomized to this intervention arm will be provided with a sparkling fruit juice enriched with the natural mastic aqueous extract (0.55%), a by-product of Chios mastic processing, and will be asked to consume it daily (3 bottles of 200 mL each) for 3 months. Participants will also be instructed to keep the use of medication and dietary supplements stable and preserve their typical lifestyle habits throughout the study.
- BEHAVIORAL
-
Placebo fruit juice
Participants randomized to this intervention arm will be provided with a standard sparkling fruit juice and will be asked to consume it daily (3 bottles of 200 mL each) for 3 months. Participants will also be instructed to keep the use of medication and dietary supplements stable and preserve their typical lifestyle habits throughout the study.
Sponsors & Collaborators
-
Harokopio University
collaborator OTHER -
Rutgers, The State University of New Jersey
lead OTHER
Principal Investigators
-
Labros Sidossis, PhD · Department of Kinesiology and Health, School of Arts and Sciences, Rutgers University
-
Michael Georgoulis, PhD · Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University
-
Alexandra Karachaliou, MSc · Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-12
- Primary Completion
- 2022-05-16
- Completion
- 2022-05-16
Countries
- Greece
Study Locations
More Related Trials
-
Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome
NCT04662957 ·Status: COMPLETED ·Phase: NA
-
The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions
NCT02888392 ·Status: COMPLETED ·Phase: NA
-
Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
NCT05990764 ·Status: RECRUITING ·Phase: NA
-
Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome
NCT02364830 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics in the Treatment of Irritable Bowel Syndrome
NCT02953171 ·Status: UNKNOWN ·Phase: NA
-
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
NCT07103772 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
NCT01886781 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Open-label vs Double-blind Treatment in IBS
NCT02802241 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
NCT00194922 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Food-derived Active Components on Digestive Tract Health in Adults with Irritable Bowel Syndrome
NCT06779214 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Probiotics in Irritable Bowel Syndrome
NCT00846170 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
NCT01641224 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
NCT02822118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome
NCT02213172 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome
NCT04364750 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome
NCT04993989 ·Status: COMPLETED
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome
NCT00786123 ·Status: COMPLETED ·Phase: NA
-
Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists
NCT01144832 ·Status: COMPLETED ·Phase: PHASE4
-
Probiotics and Irritable Bowel Syndrome
NCT04572932 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
NCT06271538 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Inulin Supplementation in Individuals With IBS-C
NCT06945302 ·Status: COMPLETED ·Phase: NA
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1